Australia has become the 30th country to eliminate trachoma as a public health problem, with the World Health Organization confirming that the infectious eye disease, once a major cause of preventable blindness in remote Indigenous communities, no longer poses a national public health threat.

The WHO validation marks the first time Australia has been officially recognized for eliminating a neglected tropical disease, placing it among 63 countries globally and the 16th in the Western Pacific region to have eliminated at least one such disease.

Trachoma is caused by the bacterium Chlamydia trachomatis and remains the world’s leading infectious cause of blindness. It spreads through close contact with infected individuals, contaminated surfaces, and flies carrying eye and nasal discharge. Repeated infections can scar the eyelids, causing eyelashes to turn inward and scratch the eye surface, eventually leading to irreversible blindness if left untreated.

WHO Director-General Tedros Adhanom Ghebreyesus said Australia’s achievement represented a major milestone both for Indigenous health outcomes and for global neglected tropical disease control efforts.“WHO congratulates Australia on this important achievement,” Tedros said in a WHO statement.

“This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities. It brings us closer to a world free from the suffering caused by trachoma.”Australia had eliminated trachoma from most of the country decades ago, but the disease persisted in remote Aboriginal and Torres Strait Islander communities, particularly in areas facing overcrowded housing, poor sanitation, and limited access to clean water and health services.

National efforts intensified in 2006 with the launch of the National Trachoma Management Programme, which adopted the WHO-recommended SAFE strategy: surgery for trichiasis, antibiotics to treat infection, promotion of facial cleanliness, and environmental improvement.

The program included regular screening of all communities classified as at risk, carried out by qualified health workers, alongside treatment and prevention campaigns delivered through cooperation between federal and state governments, Aboriginal Community Controlled Health Organisations, and local communities.

Unlike many countries where mass drug administration formed the main strategy, Australia adapted its response using targeted treatment based on community-level data and stronger integration with housing, sanitation and environmental health programs.WHO said sustained investment in screening, treatment, housing improvements, water access, sanitation and hygiene contributed to a steady decline in disease prevalence over time.

Australia’s Minister for Health and Ageing, Mark Butler, said the validation was particularly significant for communities that had carried the burden of a preventable disease for generations.“Elimination of trachoma is a win for the eye health of communities across Australia, particularly those whose lives have been impacted by a disease that is entirely preventable,” Butler said.

He said Aboriginal and Torres Strait Islander leadership had been central to the outcome, alongside long-term public investment and local health delivery.“The lessons from this work will inform how we approach other preventable health conditions in remote and regional Australia,” he said.

“Aboriginal Community Controlled Health Organisations and local health workers have been central to this success, delivering culturally safe care and community-led solutions.”

Malarndirri McCarthy, Minister for Indigenous Australians, said the recognition reflected decades of work led by First Nations health services rather than a short-term intervention.“This recognition from the World Health Organization reflects decades of work led by Aboriginal Community Controlled Health Organisations, alongside local health workers in remote First Nations communities,” McCarthy said.

“Their work has been critical to eliminating trachoma as a public health problem in Australia.”Trachoma is one of 21 diseases and disease groups classified by WHO as neglected tropical diseases, or NTDs. These diseases collectively affect more than one billion people worldwide, primarily among underserved populations with limited access to clean water, sanitation and essential health care.

WHO said Australia’s achievement demonstrated that elimination was possible even in geographically isolated and logistically difficult settings, provided political commitment and cross-sector coordination were sustained.

Saia Ma’u Piukala, WHO Regional Director for the Western Pacific, said countries across the region face similar challenges in reaching remote populations.“Tackling neglected tropical diseases in the Western Pacific Region has long been a challenge for countries across the socioeconomic spectrum,” Piukala said.

“But I also know that with strategic commitment underpinned by optimal resources and partnerships in health, success is possible.”He urged continued vigilance to ensure Australia maintains elimination status through strong surveillance and integration of monitoring systems into national healthcare structures.

WHO defines elimination of trachoma as a public health problem using three criteria: trachomatous trichiasis prevalence of less than 0.2% among adults aged 15 and above, trachomatous inflammation prevalence of less than 5% among children aged one to nine in formerly endemic districts, and a functioning system to identify and manage new trichiasis cases.

The global effort to eliminate trachoma dates back to 1996, when WHO launched the Alliance for the Global Elimination of Trachoma by 2020, known as GET2020. Although the original target year was missed, WHO’s current roadmap for neglected tropical diseases has extended the goal to 2030.

Australia now joins countries including India, China, Pakistan, Saudi Arabia, Nepal and Viet Nam among those validated by WHO for eliminating trachoma as a public health problem.Despite the success, Australia still faces several other endemic neglected tropical diseases, including Buruli ulcer, leprosy and scabies.

WHO said continued surveillance would remain essential to ensure trachoma does not re-emerge, particularly in vulnerable remote communities where access to services remains uneven.

The organization added that maintaining gains would depend on keeping surveillance systems active, integrating eye health into broader national health planning, and ensuring that improvements in housing, sanitation and healthcare access continue beyond disease elimination targets.

Coyle, currently chief of joint capabilities, will replace Lieutenant General Simon Stuart, the government said. Her appointment comes as the Australian Defence Force seeks to increase female representation and address allegations of systemic sexual harassment and discrimination.

Defence Minister Richard Marles described the move as a “deeply historic moment,” adding that Coyle’s leadership would be significant for women serving in the military and those considering enlistment.Coyle, 55, joined the army in 1987 and has held several senior command roles.

Marles said she would also become the first woman to lead any service branch within the ADF.Women currently account for about 21% of ADF personnel and 18.5% of senior leadership positions. The military has set a target of raising female participation to 25% by 2030.

The leadership changes come after a class action lawsuit filed in October alleged the ADF failed to protect thousands of female personnel from sexual assault, harassment and discrimination.

In parallel appointments, Vice Admiral Mark Hammond will become chief of the ADF, replacing Admiral David Johnston, while Rear Admiral Matthew Buckley will take over as head of the navy.

Speaking in London, Albanese said the meeting was a chance to discuss the “strongly building” support for AUKUS between the two allies but would not be drawn on the position of U.S. President Donald Trump.

The AUKUS pact, sealed in 2021, aims to provide Australia with nuclear-powered attack submarines from the next decade to counter China’s ambitions in the Indo-Pacific region.

Trump’s administration is undertaking a formal AUKUS review led by Elbridge Colby, a top Pentagon policy official and public critic of the agreement.

Asked if his meeting with Starmer gave him increased confidence that AUKUS would proceed, Albanese said: “I have always been confident about AUKUS going ahead.

“Every meeting I’ve had and discussions I’ve had with people in the U.S. administration have always been positive about AUKUS,” he said, according to an official transcript.

Under AUKUS – worth hundreds of billions of dollars – Washington will sell several Virginia-class nuclear-powered submarines to Canberra, while Britain and Australia will later build a new AUKUS-class submarine.

Australia and Britain signed a treaty in July to bolster cooperation over the next 50 years on AUKUS.

During his visit, Albanese is also expected to meet with King Charles, Australia’s official head of state.